The Indian rupee touched a historic low on Tuesday, breaching the 91-mark against the US dollar for the first time. The sharp fall highlights growing pressure on the domestic currency amid continued foreign fund outflows and weak capital inflows.
Singapore/ Jakarta [Indonesia], December 16: Synvo AI, a deep-tech spin-off from MMLab Nanyang Technological University (MMLab@NTU) Singapore, and Sobat Bisnis Group (SBG), a leading Indonesian enterprise technology company with deep ties to the multi-billion-dollar Mayapada Group, announced
India needs to rapidly scale up advanced manufacturing and frontier technologies to meet its long-term growth ambitions, Neeraj Huddar, Resident Fellow at NITI Aayog and Lead Architect of the NITI Frontier Tech Hub, said on Monday, warning that a business-as-usual approach could leave a mult
About a fortnight after breaching 90 mark, the Indian Rupee is inching towards 91, hitting a fresh all-time low. At the time of filing this report, the Rupee was trading at 90.904 per US dollar, with an intraday high of 90.957, just shy of 91.
India is entering a decisive phase of economic expansion that could redefine wealth creation over the next two decades, according to the 30th Wealth Creation Study by Motilal Oswal Financial Services.
The Indian rupee has continued to display pronounced weakness this financial year, slipping nearly 5 per cent against the US dollar and consistently trading above the 90-per-dollar mark in recent days.
The US Federal Reserve's latest 25-basis-point rate cut has set the stage for a complex global monetary backdrop, but its implications for India are expected to be relatively stable, according to analysis from YES Bank's Economics Research team.
The combination of rising financialisation, expanding equity ownership and stronger corporate profitability is creating a multi-trillion-dollar opportunity for investors, Motilal Oswal Financial Services in its Annual Wealth Creation Study (2020-2025) said.
Pranav Adani, Director, Adani Enterprises Limited (AEL), set out a data-driven vision for how India can accelerate its economic rise and how the Adani Group's infrastructure backbone is helping shape that trajectory.
Taichung [China], December 9: Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide Globally Recognized by FDA-NDI, SNQ, and the Taiwan Complementary Medicine Society (TCMS).
Congress MP Manish Tewari on Friday moved an adjournment motion in the Lok Sabha, demanding that the poor performance of the rupee be discussed in the Lower House after the Indian currency continued to decline to a new low of 90.43 against the dollar.
The rupee has fallen from Rs 85 to Rs 90 per USD in under a year, far quicker than previous five-rupee intervals, which earlier took anywhere between 581 to 1,815 days. SBI in its report noted this as the second-quickest fall since the 2013 Taper Tantrum.